Billed as a revolution, VGH now has 1 of only 4 of these...

Billed as a revolution, VGH now has 1 of only 4 of these machines in the world and only 1 in southern hemisphere.

Cateract surgery being the most common, with 200000 per year in aussy; around 4k per eye, a moderate percentage gain in market share, eg 5%, would net $40-80 million extra in revenue (more than doubling current revenue).

There's a reason PRY healthcare have been buying this stock at mid to high 20 cent range.

I've been accumulating at current share price levels, find it amusing how a bit of fear has made for such an undervalued stock.